Table 1. Non-serious and serious adverse events following administration of SA14-14-2 JE vaccine to 309,507 children aged 9 months–12 years during an immunization campaign in Cambodia, 2013.
| AEFI | Non-serious (N = 25) | Serious (N = 3) | Total (N = 28) | |||
|---|---|---|---|---|---|---|
| No. | (%) | No. | (%) | No. | (%) | |
| Vasovagal episode | 7 | (28) | 0 | (0) | 7 | (25) |
| Rash | 6 | (24) | 0 | (0) | 6 | (21) |
| Fevera | 3 | (12) | 0 | (0) | 3 | (11) |
| Meningoencephalitis | 0 | (0) | 2 | (67) | 2 | (7) |
| Hypersensitivity reactionb | 1 | (4) | 1 | (33) | 2 | (7) |
| Vomiting | 2 | (8) | 0 | (0) | 2 | (7) |
| Diarrhea | 1 | (4) | 0 | (0) | 1 | (4) |
| Crying/cyanosis | 1 | (4) | 0 | (0) | 1 | (4) |
| Pharyngitis | 1 | (4) | 0 | (0) | 1 | (4) |
| Acute respiratory infection | 1 | (4) | 0 | (0) | 1 | (4) |
| Submandibular gland infection | 1 | (4) | 0 | (0) | 1 | (4) |
| Epistaxis | 1 | (4) | 0 | (0) | 1 | (4) |
aFever without additional symptoms or signs
bOne case of generalized urticaria and one of angioedema